Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC)

Autor: Mrozek, E. *, Kolesar, J., Young, D., Allen, J., Villalona-Calero, M., Shapiro, C.L.
Zdroj: In Annals of Oncology August 2008 19(8):1417-1422
Databáze: ScienceDirect